rethinkTHC Search
Menu
Study breakdown

CBD triggered the production of immune-suppressive cells in mice through mast cells and a fat-sensing receptor

Animal StudyPreliminary evidence
The takeaway

CBD administration in mice activated mast cells and the PPAR-gamma receptor, leading to mobilization of myeloid-derived suppressor cells that potently suppressed T cell activity and reduced acute inflammation.

Read this if you're interested in the molecular mechanisms behind CBD's effects on the immune system.

PPAR-gamma antagonist completely blocked CBD's immune-suppressive effect

What the researchers found

Researchers discovered that CBD administration in mice triggered a robust immune response: the mobilization of myeloid-derived suppressor cells (MDSCs) in the abdominal cavity. These MDSCs expressed functional arginase 1 and potently suppressed T cell proliferation.

The mechanism involved mast cells and the PPAR-gamma receptor (peroxisome proliferator-activated receptor gamma). CBD was shown to enhance PPAR-gamma transcriptional activity, and blocking this receptor completely prevented MDSC induction. Mast cell-deficient mice showed markedly reduced MDSC responses.

CBD-induced MDSCs were functional: when transferred to other mice, they suppressed LPS-induced acute inflammatory responses. The findings reveal a previously unknown pathway through which CBD modulates the immune system.

Why it matters

Understanding the specific immune pathways through which CBD works is essential for developing CBD-based therapies. This study identified a concrete molecular pathway (PPAR-gamma in mast cells leading to G-CSF and MDSC mobilization) that could be targeted more precisely.

The numbers in context

CBD induced CD11b+Gr-1+ MDSCs in peritoneum. Both granulocytic and monocytic MDSC subtypes induced. Monocytic MDSCs showed higher suppressive function. MDSC induction markedly reduced in mast cell-deficient mice. PPAR-gamma antagonist completely blocked MDSC induction.

How the study worked

Controlled animal study using wild-type and mast cell-deficient (Kit-mutant) mice. CBD was administered and MDSC induction was measured by flow cytometry. Functional suppression was tested via T cell proliferation assays and adoptive transfer experiments. PPAR-gamma involvement was confirmed using reporter assays and selective antagonists.

What this study cannot tell us

Animal study using naive (healthy) mice. The immune-suppressive effects in healthy animals may not directly translate to therapeutic contexts. Long-term consequences of MDSC mobilization are unknown and could include impaired anti-tumor immunity. Doses may not translate to human use.

How to read the evidence

Detailed mechanistic animal study identifying a specific molecular pathway. No human data for this mechanism.

When this study was published

Published in 2015. CBD immunology research has continued with additional mechanistic studies.

The bigger picture

CBD's immune-modulating effects have been broadly observed but poorly understood mechanistically. This study provides one of the clearest mechanistic pathways yet, connecting CBD to immune suppression through mast cells, PPAR-gamma, and MDSC mobilization. However, immune suppression is a double-edged sword.

Questions still open

  • Could chronic CBD use suppress beneficial immune surveillance? Does this pathway operate in humans? Could the MDSC-mobilizing effect of CBD be harmful in cancer patients? Is this mechanism relevant to CBD's reported anti-inflammatory clinical effects?

Common questions

How does CBD affect the immune system?
This study found CBD activates a receptor called PPAR-gamma in mast cells, which triggers the release of a growth factor (G-CSF) that mobilizes immune-suppressive cells (MDSCs). These cells potently suppress T cell activity and reduce inflammation.
Could CBD suppress the immune system too much?
This is a legitimate concern raised by this study. While immune suppression can reduce inflammation, it could also impair the body's ability to fight infections or tumors. The clinical significance in humans is not yet known.

Read the original research

Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.

Journal of immunology (Baltimore, Md. : 1950), 194(11), 5211-22

Citation

Hegde, Venkatesh L; Singh, Udai P; Nagarkatti, Prakash S; Nagarkatti, Mitzi. (2015). Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.. Journal of immunology (Baltimore, Md. : 1950), 194(11), 5211-22. https://doi.org/10.4049/jimmunol.1401844

Explore the wider topic